Company: PSTV
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013256
Chunk: 5

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 5
---
uance Proposal”); |

| • | Proposal 3: To amend the Certificate of Incorporation to increase the authorized shares of Common Stock from 100,000,000 shares to 2,000,000,000 shares (the “Authorized Common Stock Increase Proposal”); |

| • | Proposal 4: To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the extension of the term of the Company’s May 2024 Warrants (as defined elsewhere in this Proxy Statement) (the “Warrant Amendment Proposal”); |

| • | Proposal 5: To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal, the Issuance Proposal, the Authorized Common Stock Increase Proposal and the Warrant Amendment Proposal, if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal, the Issuance Proposal, the Authorized Common Stock Increase Proposal or the Warrant Amendment Proposal (the “Adjournment Proposal”); and |

| • | To transact any other business that may properly come before the Special Meeting or any adjournment(s) or postponements of the Special Meeting. |

2

TABLE OF CONTENTS

What are the Board’s voting recommendations? The Board recommends that you vote as follows:

| • | Proposal 1 (Reverse Stock Split Proposal): “FOR” the Reverse Stock Split Proposal; |

| • | Proposal 2 (Issuance Proposal): “FOR” the Issuance Proposal; |

| • | Proposal 3 (Authorized Common Stock Increase Proposal): “FOR” the Authorized Common Stock Increase Proposal; |

| • | Proposal 4 (Warrant Amendment Proposal): “FOR” the Warrant Amendment Proposal; and |

| • | Proposal 5 (Adjournment Proposal): “FOR” the Adjournment Proposal. |

Who is entitled to vote at the Special Meeting? Holders of record of our Common Stock, as of the close of business on March 4, 2025, the record date for the Special Meeting (the “Record Date”), are entitled to receive notice of the Special Meeting. Holders of record of shares of Common Stock have the right to vote on all matters brought before the Special Meeting. Holders of the shares that were purchased in the offering that was consummated on March 4, 2025, shall not be entitled to vote those shares purchased in that offering on Proposal 2